Neuburgh Advisers’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
2019
Q2
$65K Hold
2019
Q1
$49K Hold
2018
Q4
$29K Sell
2018
Q3
$97K Buy
2018
Q2
$71K Buy